These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 526402)

  • 41. [Hypotensive effect and changes of arterial pressure variability induced by treatment with labetalol in patients with slight and moderate arterial hypertension].
    Palatini P; Pessina AC; Sperti G; Ventura E; Agnoletto V; Semplicini A; Hlede M; Gava R; Mormino P; Dal Palù C
    G Ital Cardiol; 1983; 13(1):18-22. PubMed ID: 6873535
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Comparative effects of an alpha 1 and beta 1-2 blocker (labetalol) and a beta-1 blocker (atenolol) in the hypertensive patient].
    Sassard J; Zech PY; Pozet N; Cuisinaud G; Vincent M
    J Pharmacol; 1983; 14 Suppl 2():121-9. PubMed ID: 6355664
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Controlled comparison of labetalol and propranolol in the management of severe hypertension.
    Pugsley DJ; Armstrong BK; Nassim MA; Beilin LJ
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):777-82. PubMed ID: 791331
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Labetalol, an alpha- and beta-adrenoceptor-blocking agent: its use in therapeutics. A summary of the symposium.
    Prichard BN; Richards DA
    Br J Clin Pharmacol; 1979; 8(Suppl 2):239S-244S. PubMed ID: 526408
    [No Abstract]   [Full Text] [Related]  

  • 45. Blood pressure, plasma volume, extracellular volume and glomerular filtration rate during treatment with labetalol in essential hypertension.
    Rasmussen S; Nielsen PE
    Postgrad Med J; 1980; 56 Suppl 2():33-6. PubMed ID: 7433340
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Labetalol in resistant hypertension.
    Dargie HJ; Dollery CT; Daniel J
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):751-5. PubMed ID: 990154
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Labetalol in the treatment of angina pectoris.
    Kanto JH
    Int J Clin Pharmacol Ther Toxicol; 1987 Mar; 25(3):166-74. PubMed ID: 2881899
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of the alpha and beta blocking effects of intravenous labetalol on left ventricular function in coronary artery disease.
    Gagnon RM; Presant S; Morissette M
    Can J Cardiol; 1985; 1(4):259-62. PubMed ID: 2996729
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diazoxide vs labetalol: a cross-over comparison of short-term effects in hypertension.
    Rumboldt Z; Bagatin J; Vidovic A
    Int J Clin Pharmacol Res; 1983; 3(1):47-54. PubMed ID: 6679507
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Labetalol in the treatment of arterial hypertension. A Brazilian multicenter study].
    Benchimol AB; Sbissa AS; Benchimol CB; Saad EA; Barbosa ET; Albanesi Filho FM; Pillegi F; da Cunha GP; Maranhão MF; Batlouni M; Schlesinger P; Duprat R; Maciel R
    Arq Bras Cardiol; 1982 May; 38(5):421-7. PubMed ID: 6762868
    [No Abstract]   [Full Text] [Related]  

  • 51. The effects of labetalol and prazosin on exercise haemodynamics in hypertensive patients.
    Feit A; Cohen M; Dimino L; el-Sherif N; Holtzman R; Venkata C; Ram S; Gaffeny D; Heller J; Kaplan N
    J Hum Hypertens; 1991 Feb; 5(1):39-43. PubMed ID: 2041034
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Treatment of arterial hypertension with labetalol. A polycentric study].
    G Ital Cardiol; 1982; 12(10):729-35. PubMed ID: 7182212
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment of severe hypertension by repeated bolus injections of labetalol.
    Cumming AM; Brown JJ; Lever AF; Mackay A; Robertson JI
    Br J Clin Pharmacol; 1979; 8(Suppl 2):199S-204S. PubMed ID: 393288
    [No Abstract]   [Full Text] [Related]  

  • 54. [Own experience with labetalol - a new adrenergic alpha and beta receptor blockader - in the treatment of arterial hypertension].
    Cybulska I; Sznajderman M; Brym E; Czerniewska E
    Pol Tyg Lek; 1981 Aug; 36(34):1309-11. PubMed ID: 7038638
    [No Abstract]   [Full Text] [Related]  

  • 55. The value of combined alpha- and beta-adrenoceptor blockade in angina pectoris.
    Mulac KD
    Postgrad Med J; 1983; 59 Suppl 3():33-4. PubMed ID: 6647207
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Haemodynamic effects of long-term oral labetalol.
    Edwards RC; Raftery EB
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):733-6. PubMed ID: 791328
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A multicentre study of labetalol in hypertension. New Zealand Hypertension Study Group.
    N Z Med J; 1981 Apr; 93(681):215-8. PubMed ID: 7017511
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Use of labetalol during anesthesia for pheochromocytoma removal.
    Van Stratum M; Levarlet M; Lambilliotte JP; Lignian H; de Rood M
    Acta Anaesthesiol Belg; 1983 Dec; 34(4):233-40. PubMed ID: 6673473
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Labetalol compared with propranolol in patients with both angina pectoris and systemic hypertension: a double-blind study.
    Frishman WH; Shapiro W; Charlap S
    J Clin Pharmacol; 1989 Jun; 29(6):504-11. PubMed ID: 2666451
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A double-blind comparison of verapamil and labetalol in hypertensive patients with coexisting chronic obstructive airways disease.
    Anavekar SN; Barter C; Adam WR; Doyle AE
    J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S374-7. PubMed ID: 6184571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.